Evidence map›Paper›PMID 41795682›Full record

ArticleNano letters2026

Bioengineered Protein Stabilized Perovskite Nanoplates in Polar Solvents.

Emma H Massasa, Oren Bachar, Arad Lang, Omer Yehezkeli, Yehonadav Bekenstein

Abstract read
In one paragraph

Article in Nano letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Emma H MassasaDepartment of Materials Science and Engineering, Technion - Israel Institute of Technology, 3200003 Haifa, Israel.ORCID 0000-0002-6803-5379
Oren BacharFaculty of Biotechnology and Food Engineering, Technion - Israel Institute of Technology, 3200003 Haifa, Israel.
Arad LangDepartment of Materials Science and Engineering, Technion - Israel Institute of Technology, 3200003 Haifa, Israel.ORCID 0000-0003-3692-7628
Omer YehezkeliFaculty of Biotechnology and Food Engineering, Technion - Israel Institute of Technology, 3200003 Haifa, Israel.ORCID 0000-0001-7588-6705
Yehonadav BekensteinDepartment of Materials Science and Engineering, Technion - Israel Institute of Technology, 3200003 Haifa, Israel.ORCID 0000-0001-6230-5182

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Colloidally stabilized halide perovskite nanoparticles are promising for photocatalysis due to high absorption cross-section, high photoluminescence quantum yield, and nanoscale dimensions comparable to molecular reactants. Yet, their ionic lattice limits stability in polar media, complicating integration into aqueous catalytic systems. Here, we utilize stable protein 1 (SP1) as a bioinspired capping layer to protect perovskite nanoparticles from polar degradation while preserving their optoelectronic functionality, which stems from SP1's amphiphilic nature, featuring a hydrophilic exterior and a hydrophobic interior. Using bioengineered SP1 and its monomeric derivatives, we synthesize perovskite nanoplates with tunable quantum confinement that remain stable in an isopropanol polar environment. Protein screening reveals that stability in organic solvents, combined with suitable surface amine and carboxylate distributions, is crucial for nanoplate formation and stability, resulting in hybrids with superior spectroscopic stability in polar media. These findings provide design rules for protein-stabilized perovskites, paving the way for future solution-phase biocatalytic systems.

Indexed as

Bioengineered protein scaffoldsBiotic-abiotic interfaceColloidal synthesisLead halide perovskitesNanomaterialsProtein-templated nanocrystalsStability

Identifiers

PMID41795682
PMCPMC13003495

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.